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Abstract: The High Mobility Group Box 1 (HMGB1) is the most abundant nuclear nonhistone protein
that is involved in transcription regulation. In addition, HMGB1 has previously been found as an
extracellularly acting protein enhancing neurite outgrowth in cultured neurons. Although HMGB1 is
widely expressed in the developing central nervous system of vertebrates and invertebrates, its function
in the developing mouse brain is poorly understood. Here, we have analyzed developmental defects
of the HMGB1 null mouse forebrain, and further examined our findings in ex vivo brain cell
cultures. We find that HMGB1 is required for the proliferation and differentiation of neuronal
stem cells/progenitor cells. Enhanced apoptosis is also found in the neuronal cells lacking HMGB1.
Moreover, HMGB1 depletion disrupts Wnt/β-catenin signaling and the expression of transcription
factors in the developing cortex, including Foxg1, Tbr2, Emx2, and Lhx6. Finally, HMGB1 null
mice display aberrant expression of CXCL12/CXCR4 and reduced RAGE signaling. In conclusion,
HMGB1 plays a critical role in mammalian neurogenesis and brain development.
Keywords: HMGB1; brain development; neurogenesis; differentiation; CXCL12; CXCR4
1. Introduction
The High Mobility Group Box 1 protein (HMGB1, alias is HMG1 and Amphoterin) is a conserved
protein that is widely expressed in almost all types of cells from embryo to adulthood [1,2]. HMGB1 is
not only the main parental member of the HMG protein family involved in intracellular regulation, but it
also has extracellular regulatory functions that are related to development, disease, and inflammation.
Extracellular HMGB1 was initially found as a heparin-binding protein abundantly expressed
in the embryonic rat brain [3,4]. HMGB1 secreted from neurons and from non-neuronal cells [5,6],
mainly signals through the RAGE (Receptor for Advanced Glycation End products) receptor [7,8],
and it plays an essential role in neurite outgrowth and neuronal migration in the developing nervous
system [9]. In recent years, the extracellular functions of HMGB1 have been intensively investigated.
HMGB1 is released by the immune cells and platelets under special stimuli, such as infection or injury,
and it is crucial for cell migration, differentiation, and activation [10–12]. HMGB1 has been described
as an alarmin or damage-associated molecular pattern (DAMP) molecule as for the central role of
HMGB1 in inflammation and a relevant molecule in immune responses against tumor formation [13].
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HMGB1 has been found to be highly expressed in the developing central nervous system (CNS)
across different species [14–17]. Interestingly, HMGB1 shows a specific dynamic expression pattern in
the embryonic mouse brain. It is highly expressed in the dorsal telencephalon until E16 (Embryonic day
16) and decreases dramatically after E18 [18], which suggests its involvement in neurogenesis during
early development of the brain. When compared to pathophysiological roles of HMGB1 in the immune
system, its role in the CNS is not well understood.
Recently, HMGB1 was found to form a HMGB1-CXCL12 heterocomplex that signals through
CXCR4 in leukocytes [19]. HMGB1 and CXCL12/CXCR4 chemotaxis play an important role in
recruiting immune cells to the site of inflammation. CXCL12/CXCR4 signaling regulates cerebellar
granule cell development [20–22], neurogenesis, and neuronal migration in the developing CNS [23,24].
Furthermore, CXCL12/CXCR4 is critical for the development of the hippocampal dentate gyrus, the site
of active adult neurogenesis [25]. CXCL12 expression increases at the site of apoptosis in the developing
brain, followed by an increased presence of microglia at the apoptotic site [26]. HMGB1 is also found to
be required for the microglia activation in the neuroinflammatory responses [27]. The high expression
of HMGB1 and CXCL12/CXCR4 has been found to be coordinated in the prenatal cortex, while there is
short of evidence of HMGB1 and CXCL12/CXCR4 signaling in the nervous system as compared to the
immune system [28,29].
Our study has investigated HMGB1 in vivo function in the developing mammalian brain for the
first time using the HMGB1 knockout (KO) mice. We have found dramatically reduced neurogenesis
and differentiation in the developing brain of the HMGB1 KO mouse embryos. HMGB1 knockout mice
showed prominent forebrain hypoplasia at early developmental stage. Such defects in the HMGB1 KO
mouse embryos have been proven by aberrant expression of multiple neuro-developmental transcription
factors shown by in situ and qRT-PCR analyses. Furtermore, we have clearly demonstrated that
HMGB1 is required for maintaining CXCL12/CXCR4 expression in the developing brain by both in vivo
and in vitro immunohistochemistry results. Our data provide the first evidence that the HMGB1
dependent CXCL12/CXCR4 signaling pathway also exists in the mammalian developing CNS.
2. Materials and Methods
2.1. Animals
Original strain of Hmgb1+/− mice (CBA/C57BL background) has been kindly provided by Professor
Marco Bianchi’s lab. The pleiotropy of Hmgb1−/− phenotypic defects is consistent across different
genetic backgrounds. The original Hmgb1+/− male mice were bred to the CD-1 mouse strain in
order to elevate their fertility. The Hmgb1+/− hybrids were used for producing Hmgb1−/− littermates.
In breedings, the day of detection of the vaginal plug was determined as E0. HMGB1 knockout
(KO) mouse genotyping has been done according to the previous description [30]. The animal
experiment permits were obtained from the Office of the Regional Government of Southern Finland
(license number ESAVI/6603/04.10.03/2011) in agreement with the ethical guidelines of the European
convention. All experimental protocols were carried out in accordance with the approved guidelines
of the Laboratory Animal Centre (LAC) of the University of Helsinki.
2.2. Bromodeoxyuridine (BrdU) Labeling of Neuronal Progenitors In Vivo
BrdU was dissolved in sterile saline and injected intraperitoneally into pregnant dams at the
saturating dose of BrdU (50 µg/g body weight, two times injection with a 6-h interval) one day before
collecting the embryos. Multiple injections were used to ensure the labeling of most cells undergoing
cell divisions over the period of cell cycle in dorsal telencephalon [31,32]. Within 2 h after the successive
BrdU injections, pregnant mice were sacrificed and E10 and E16 embryos were collected and then
fixed in 4% paraformaldehyde by immersion and embedded in paraffin. Sections of 15 µm were
cut and immunostaining was done with rat anti-BrdU antibody (ab6326, Abcam, Cambridge, MA)
in 1:300 dilution after pretreatment of the tissue with 1 N hydrochloric acid for 15 min. at 37 ◦C,
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followed by 5 min. in borate buffer. Subsequently, 3,3′-Diaminobenzidine (DAB) colorimetric staining
was used for immunodetection with horseradish peroxidase (HRP) conjugated secondary antibodies.
In the end, the stained sections were mounted by UltraKitt™ (Biosystem Switzerland AG, Muttenz,
Switzerland) mounting media after dehydration. For the WT and KO embryos, both sagittal and
coronal sections were continuously collected with the interval of 60 µm (thickness of the section is
15 µm, one section was attached to the glass when cutting four sections off). All of the sections from
the same embryo were clearly numbered by the sequence of collection. The sections of the WT and KO
embryos were anatomically aligned by referring to Kaufman’s Atlas of Mouse Development and the
Allen Developing Mouse Brain Atlas (2015).
2.3. In Situ Hybridizations and Histology
E16 embryo paraffin sections were prepared, as above. In situ RNA hybridization on dehydrated
E16 embryo sections was performed in the InSitu ProVSi device (Intavis AG, Köln, Germany) [14].
Luca Muzio’s laboratory kindly offered Tbr2, Emx2, Foxg1, and CXCL12 cDNA for antisense and
sense probes [26,33,34]. CXCR4 RNA probes were generated, as described [22]. Lhx6 cDNA fragment
(TC1570995.1) was produced for synthesizing the RNA probe according to the information on the
webpage of Allen Mouse Brain Atlas.
Mayer’s Hematoxylin (Thermo Fisher Scientific, Waltham, MA, USA) was used for nuclear
counterstaining of E16 embryo sections following the recommended protocol. The colorimetrically
stained sections were mounted by UltraKitt™ mounting media after dehydration.
2.4. qRT-PCR Array
Total RNA from E16 embryonic brain was extracted with NucleoSpin RNA kit (Macherey-Nagel
GmbH & Co. KG, Düren, Germany). RNA was reverse-transcribed as described [14]. Tested genes were
selected based on Mouse neurogenesis & differentiation RT2 Profiler™ PCR Array (Qiagen, Hilden,
Germany). Tested qRT-PCR primers of Ascl1, Bmp2, Bmp4, Hes1, Neurod1, Neurog1, Neurog2, Olig2,
Sox2, Shh, Ntf3, Pax6, Notch2, Ache, Wnt1, Wnt3, Bdnf, Egf, Gdnf, Fgf2, Cxcl1, Tgfb1, Tbr2, Emx2, Apoe,
and Bcl2 (including β-Actin, Gapdh and Rpl13a as reference genes) were ordered from Sigma-Aldrich
(St. Louis, MO, USA). The Cxcl12 primers were 5′-TGC ATC AGT GAC GGT AAA CCA -3′ and 5′-GTT
GTT CTT CAG CCG TGC AA- 3′. Cxcr4 primers were 5′- GAC TGG CAT AGT CGG CAA TG -3′ and
5′-AGA AGG GGA GTG TGA TGA CAA A- 3′. The Cxcr7 primers were 5′-CCT AAC AAG AAC
GTG CTT CTG T- 3′and 5′-GTG GTC TTA GCC TGG ATA TTC AC- 3′. The Amigo1 primers were
5′-TCG GTG AGC GTG AGG AAT G -3′ and 5′- CCC ACC AGG GTA GTG TAG G-3′. The PCRs were
processed with the Bio-Rad CFX96 real-time PCR machine using the CFX96™ real-time PCR detection
system (Bio-Rad Laboratories Inc., Hercules, CA). The LuminoCt™ SYBR Green qPCR ReadyMix™
(Sigma-Aldrich) was used with the PCR protocol as before [14].
2.5. Fluorescence-Activated Cell Sorting (FACS)
Dissected embryonic E14.5 brains were titrated in FACS buffer (PBS - 1% Fetal calf serum - 0.02%
NaN3) using pipette tip, and filtered through 70-µm cell strainers (Fisher Scientific, Hampton, NH).
Single cell suspensions were blocked with 10% normal rat serum on ice for 30 min., and stained with a
combination of anti-mouse cell surface flow cytometric markers CD11b-FITC (BioLegend, San Diego,
CA), GLAST-PE, and O4-APC (Miltenyi Biotec, Bergish Gladbach, Germany) at 4 ◦C in dark for 1 h
with continuous rotation. The stained cells were then washed, centrifuged, and resuspended into 1 mL
of FACS buffer, and acquired on a two-laser, six-color Gallios cytometer (Beckman Coulter, Pasadena,
CA). The threshold for FACS analysis was set based on the surface expression of each individual
marker in the samples as compared to isotype control using IgG-stained cells in the same channel,
and Flow cytometric data were analyzed with the Kaluza 1.3 software (Beckman Coulter, Brea, CA),
as reported [35,36]. Cell populations were calculated as the percentages among the total cells.
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2.6. Primary Neuronal Cultures
Primary cortical neurons were prepared from both E14 and E16 pup cortex. The cleared cell
suspension containing 80–90% of neurons or neuronal precursors was collected and plated for the
assays [5]. The cells were cultured in neurobasal medium (Thermo Fisher Scientific) with B27
supplement (Thermo Fisher Scientific) and penicillin–streptomycin and used at two, four, and seven
days in vitro for treatments and/or immunocytochemistry. For each brain, the harvested cortical
neurons were divided into four wells on the 24-wells plate that was coated with ploy-l-lysine and
cultured with or without HMGB1 recombinant protein (recHMGB1). recHMGB1 was previously
produced in animal cells and shown to correspond in its properties to HMGB1 isolated from rat
brain [37]. For recHMGB1 supply in the cell culture, 20 µg/mL recHMGB1 were coated to the plate for
1 h at room temperature and the wells were then washed by culture medium. The suspended cells
were added into the wells with equal volume (4–5 × 105 cells) containing 10 µg/mL recHMGB1 [37,38].
For maintaining the concentration of recHMGB1 in the cell culture, the culture medium was replaced
every 48 h by freshly prepared 10 µg/mL recHMGB1 in the cell culture medium. The cultures were
incubated for 2, 4 or 7 days before fixation as defined in each experiment.
2.7. Antibodies, Western Blotting and Immuno-Cytochemistry
Affinity-purified Rabbit-anti-HMGB1 antibody (1 mg/mL) against the peptide
KFKDPNAPKRPPSA that corresponds to the residues 87–100 of the rat HMGB1 sequence
was used for Western blotting and fluorescent immunostaining (1:1000) [14,39]. Rabbit Anti-CXCR4
(Polyclonal, Abcam, Cambridge, UK; ab2074, 1 mg/mL, 1:400) and anti-CXCL12 (1 mg/mL; 1:200) were
used for Western blotting and fluorescent immunostaining. Rabbit anti-PCNA antibody (1 mg/mL,
Abcam, ab15497, 1:200) was used for fluorescent immunostaining. The Rabbit-anti-mouse AMIGO1
antibodies (1 mg/mL, Neuromab, Davis, CA; 28330) were used in western blotting (1:1000) and
fluorescent immunostaining (1:500). Goat anti-RAGE (Fisher Scientific, AF1145SP) antibody was
used for Western blotting (1 mg/mL, 1:2000). The rabbit anti-NeuN antibody (Invitrogen, PA5-78499),
mouse anti-glial fibrillar acidic protein (GFAP) antibody (Fisher Scientific, 50-175-341) and mouse
anti-β-Tubulin III (Tuj1) antibody (Sigma, T8578) were used for fluorescent immunostaining (1 mg/mL;
1:500). Anti-β-catenin antibodies (1 mg/mL, 1:400; C2206 Rabbit polyclonal, Sigma-Aldrich) were
used for Western blotting and fluorescent immunostaining. Mouse monoclonal anti-β-actin antibody
(A2228, 1:2000, Sigma-Aldrich) was used as a control of sample loading in Western blotting.
E16 mouse cortex was dissected and homogenized with rotor–stator homogenizer. The primary
neuronal cells and tissue samples were lysed by SDS extraction buffer [40], and 15 µL of cell or tissue
lysate was used for SDS-PAGE. Proteins were transferred to HybondTM nitrocellulose membrane
(Amersham Biosciences, Little Chalfont, UK) by a semidry blotting technique with transblotting cell
(Bio-Rad) and detected with the antibodies. After the HRP-conjugated secondary antibody incubation,
the samples were visualized with the ECL Western blotting detection system (Amersham Biosciences).
For immunohistochemistry of E10, E12, E14, and E16 embryonic sections, the embryos at each
developmental stage were collected. The torsos were used for genotyping. The dissected embryos
were fixed in 4% PFA overnight at 4 ◦C. The fixed samples were processed by dehydration and
paraffin embedding and cut into 10 µm sections. The rehydration and antigen retrieve of paraffin
sections was done as introduced before [41]. The hydrated tissue sections and cell culture slides for
immunostaining were then fixed in 4% PFA for 30 min. at room temperature. The sections were
washed and preincubated in phosphate-buffered saline containing 0.1% Tween 20 (PBS-T, pH 7.4)
and 4% normal goat serum at 4 ◦C overnight or longer. The specimens were incubated with the
primary antibodies in the preincubation solution (PBS-T with 2% normal goat serum) for 3 h at
room temperature. The samples were then washed thoroughly with PBS-T and incubated with the
Alexa®-conjugated goat anti-rabbit (Alexa488), Donkey anti-goat (Alexa488 & Alexa546), or goat
anti-mouse (Alexa568) secondary antibodies (diluted 1:2000) in the preincubation solution for 2 h at
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room temperature or overnight at 4 ◦C. The fluorometric TUNEL system (Alexa® 488, DeadEndTM,
Promega) was used for staining of apoptosis in whole mounts.
Immunocytochemistry of primary neurons was carried out, as described [41,42]. The stained
neuronal cells were finally counter-stained with nuclear stain DAPI (Molecular Probes, Inc., Eugene,
OR). The samples were washed with PBS-T twice for 15 min. each, three times with PBS for 10 min.
each time, and covered by mounting medium (Fluoromount™ Aqueous, Sigma-Aldrich).
2.8. Imaging
Zeiss LSM 710 and LSM 780 confocal microscopy system (Carl Zeiss MicroImaging GmbH, Jena,
Germany) were used for imaging embryo sections and cultured cell slides. Stacks of images that were
taken at 1 µm intervals were compiled to make maximum intensity projection images. The specimens
from in situ hybridization were examined with inverted light microscopy using Olympus IX 70 that was
connected through a CCD camera to the Analysis® software (Olympus, Tokyo, Japan). High resolution
images were obtained with a digital MicroFire S99808 camera (Optronics, Goleta, CA) that was attached
to Olympus BX51 epifluorescence microscope (Olympus). The acquired images were further processed
with CorelDRAW® Graphics Suite X6 (Corel Corporation, Ottawa, Canada).
2.9. Image Analyses
Confocal images of cell cultures were processed by Zeiss Efficient Navigation (ZEN 2012) software
(Carl Zeiss MicroImaging GmbH) with single maximum intensity z-stacking projections containing the
whole image stacks. The intensities of the Western blotting bands were examined with Quantity One
version 4.6.2 (Bio-Rad). The measurement of BrdU and Hematoxylin staining in dorsal telencephalon
were carried out using Fiji (ImageJ Version: 2.0.0-rc-69/1.52p). The BrdU staining cells and DAPI
staining nucleus were counted by “Analyze Particles” build-in of Fiji. The anti-HMGB1, anti-PCNA
antibody staining cells, and Tunel staining cells were counted by “Cell Counter” plug-in of Fiji.
The collected primary neuronal cells from each brain were equally distributed and then cultured in
three wells for three independent analyses. The average of the three wells was used for statistical
analyses in groups.
2.10. Statistical Analyses
Unpaired t-test (two-tailed) has been carried out using OriginPro version 9.0.
(OriginLab Corporation, Northampton, MA). Measurements are given in mean ± Standard deviation
(SD) and Standard error mean (SEM), unless stated otherwise.
3. Results
3.1. Depletion of HMGB1 Results in Severe Defects in Brain Morphogenesis
HMGB1 KO mice were produced each time by dihybrid cross from HMGB1 heterozygous
parents. HMGB1 heterozygous mice do not have prominent abnormalities and they produce offsprings
normally [30]. The mouse embryos at E10 and E16 stage were used for the comparison of dorsal
telencephalon between the HMGB1 KO and the WT embryos. All of the mouse embryos were collected
from the uterus after careful plugging. Strikingly, the HMGB1 KO embryos showed significant
morphogenesis defects.
When compared to the WT embryos, the HMGB1 KO embryos are much smaller, and the defects
in brain development can be clearly seen by BrdU staining already from E10 stage (Figure 1A).
The depletion of HMGB1 expression in HMGB1 KO embryos was confirmed by the immunostaining
of E10 sections and primary neuronal culture of E16 developing cortex with anti-HMGB1 antibody
(Figure 1B,E). The HMGB1 KO had gross defects in Tel (telencephalic vesicle), which did not show the
normal expansion towards dorsal-rostral direction as in the WT control (Figure 1A). The HMGB1 KO
also showed decreased anti-PCNA staining in the dorsal telencephalon as compared to WT at E10
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(Figure 1B). Notably, the neuroepithelial thickness of the dorsal pallium and hindbrain in the HMGB1
KO decreased dramatically when compared to the WT at E10 (Figure 1C). At E16, the morphological
difference between the KO and the WT was even more clear (Figure 1D). HMGB1 expression was
detected in over 80% of neuronal cells in the primary neuronal culture from the E16 WT embryos,
but not from the KO embryos (Figure 1E,F). Only ~20% of HMGB1 expressing cells showed much
higher HMGB1 expression in the nucleus than in the cytoplasm (Figure 1F).
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Figure 1. Morphogenesis and proliferation defects of the prenatal HMGB1 knockout (KO) mouse. (A) 
Bromodeoxyuridine (BrdU) stained sagittal sections of the E10 embryo from the HMGB1 KO and the 
WT control. The decreased BrdU staining in the dorsal neopallial cortex is indicated with *. Scale bar 
indicates 500 µm. (B) Whole mount immunostaining of sagittal sections of E10 dorsal telencephalon 
with anti-HMGB1 (Green) and anti-PCNA (Red) antibodies. HMGB1 was not detected in the HMGB1 
KO. PCNA staining was grossly decreased in the rostral anterior part of the dorsal telencephalon 
(indicated with ***). Scale bar indicates 400 µm. (C) Statistics of the thickness of E10 neuroepithelium. 
The BrdU stained sections from six KO and six WT embryos were compared. The HMGB1 KO showed 
significantly decreased BrdU staining in dorsal telencephalic ventricle and hindbrain. D Tel, dorsal 
telencephalic ventricle; Ve Tel, ventral telencephalic ventricle; M, midbrain; H, hindbrain. Mean 
values ± S.D. (error bars) and S.E.M (Boxes) are indicated (n = 6; * p < 0.001, unpaired t-test, two-tailed). 
(D) Lateral view of the E16 KO and the WT embryos. Scale bar indicates 5 mm. (E) Immunofluorescent 
staining of in vitro one day cultured E16 cortical neurons with anti-HMGB1 antibody (Green). Arrows 
show cells with high HMGB1 expression in nucleus. Scale bar indicates 20 μm. (F). The statistics of 
HMGB1 expressing cells in cultured E16 cortical neurons. The cortical neurons from five KO and five 
WT E16 brains were collected. Mean values ± S.D. (error bars) are indicated (n = 5; *** p < 0.001, 
unpaired t-test, two-tailed). 
Figure 1. Morphogenesis and proliferation defects of the prenatal HMGB1 knockout (KO) mouse.
(A) Bromodeoxyuridine (BrdU) stained sagittal sections of the E10 embryo from the HMGB1 KO and
the WT control. The decreased BrdU staining in the dorsal neopallial cortex is indicated with *. Scale bar
indicates 500 µm. (B) Whole mount immunostainin f sagittal sections of E10 dorsal telencephalon
with anti-HMGB1 (Green) and anti-PCNA (Red) antibodies. HMGB1 was not detected in the HMGB1
KO. PCNA staining was grossly decreased in the rostral anterior part of the dorsal telencephalon
(indicated with ***). Sc le bar indicates 400 µm. (C) Statistics of the thickness of E10 neuroepithelium.
The BrdU stained sections from six KO a six WT embryos were compared. The HMGB1 KO
showed significantly decreased BrdU staining in dorsal telencephalic ventricle and hindbrain. D Tel,
dorsal telencephalic ventricle; Ve Tel, ventral telencephalic ventricle; M, idbrain; H, hindbrain.
Mean values ± S.D. (erro bars) and S.E.M (Boxes) are indicated (n = 6; * p < 0.001, unpaired t-test,
two-tailed). (D) Lateral view of the E16 KO and the WT embryos. Scale bar indicates 5 mm.
(E) Immunofluorescent staining of in vitro one day cultured E16 cortical neurons with anti-HMGB1
antibody (Green). Arrows show cells with high HMGB1 expression in nucleus. Scale bar indicates
20 µm. (F). The statistics of HMGB1 expressing cells in cultured E16 cortical neurons. The cortical
neurons from five KO and five WT E16 brains were collected. Mean values ± S.D. (error bars) are
indicated (n = 5; *** p < 0.001, unpaired t-test, two-tailed).
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The brain developmental defects were further investigated by BrdU labeling of the sagittal sections
of E16 embryos (Figure 2A,B). The BrdU labeling of E16 sections clearly showed that the HMGB1 KO
embryos had less proliferating neuronal cells in dorsal telencephalon than the WT embryos (Figure 2A).
The HMGB1 KO mice showed significantly decreased numbers of BrdU+ cells in the cortical layers
under higher magnification (Figure 2B). As compared to the WT mice, the HMGB1 KO mice showed
over 40% decreased numbers of BrdU+ cells in the intermediate zone (IZ), about 15–30% decrease in
the subventricular zone (SVZ) and ventricular zone (VZ), and about 20% decrease in the cortical plate
(CP) (Figure 2C).
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Figure 2. (A) Sagittal sections of E16 embryos with BrdU staining. Scale bar indicates 500 µm. The 
black rectangles are the areas shown in B. (B) BrdU staining of E16 dorsal telencephalon under higher 
resolution. Scale bar indicates 100 µm. (C) Statistics of the BrdU+ cell numbers in the E16 cortical layers 
of the KO and WT embryos. For each brain, BrdU+ cell numbers in each layer were counted five times 
at different sections for averaging. The stained sections from 5 KO and 5 WT embryos were used for 
comparison. Mean values ± S.D. (error bars) and S.E.M (Boxes) are indicated (n = 5; *** p < 0.001; * p < 
0.05, unpaired t-test, two-tailed). (D) Sagittal sections of E16 embryos with hematoxylin staining. The 
areas in red rectangle were zoomed out in (E) Scale bar indicates 500 µm. (E) The E16 cortical layers 
in the dorsal pallium (Dpa) with hematoxylin stains. Scale bar indicates 150 µm. (F) Statistics of the 
thickness of E16 cortical layers. Each layer has been measured on three different sections at central 
position for each embryo. Sections from six KO and six WT mice have been measured. Mean values ± 
S.D. (error bars) and S.E.M (Boxes) are indicated (n = 6; **, p < 0.01; *, p < 0.05, unpaired t-test, two-
tailed). (G) The Tunel staining of E12 sagittal sections. The strong apoptotic signaling in the dorsal 
neopallial cortex (NPC) and subpallium (Spa) of the HMGB1 KO is indicated by white arrows. The 
area in the white rectangle has been amplified. The intermediate layer of NPC showed highest 
apoptotic activity (***). Scale bar indicates 200 µm in the upper panel and 100 µm in the lower panel. 
Abbreviations: AOV, ventral anterior olfactory area; CP, cortical plate; Dpa, dorsal pallium/isocortex; 
H, hindbrain; HI, hippocampus; IZ, intermediate zone; M, midbrain; MAR, marginal layer; NPC, 
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Figure 2. (A) Sa ittal sections of E16 embry with BrdU staining. S ale bar indicates 500 µm.
The black rectangles are the areas shown in B. (B) BrdU staining of E16 dorsal telencephalon under
higher resolution. Sc le bar indicates 100 µm. (C) Statistics of the BrdU+ c ll numbers in the
E16 cortical layers of the KO and WT embryos. For each brain, BrdU+ cell numbers in each layer
were counted five times at different sections for averaging. The stained sections from 5 KO and
5 WT embryos were us d for comparis n. Me n values ± S.D. (error bars) and S.E.M (Boxes)
are indicated (n = 5; *** p < 0.001; * p < 0.05, unpaired t-test, two-tailed). (D) Sagittal sections of E16
embryos with hematoxylin staining. The areas i red rectangle wer zoom d out in (E) Scale bar
indicates 500 µm. (E) The E16 cortical layers in the dorsal pallium (Dpa) with hematoxylin stains.
Scale bar indicates 150 µm. (F) Statistics of the thickness of E16 cortical layers. Each layer has been
measured on three different sections at ce tral position for each embryo. Sections from six KO and
six WT mice have been measured. Mean values ± S.D. (error bars) and S.E.M (Boxes) are indicated
(n = 6; **, p < 0.01; *, p < 0.05, unpaired t- st, two-tailed). (G) The Tunel st ining of E12 sagittal
sections. The strong apoptotic signaling in the dorsal neopallial cortex (NPC) and subpallium (Spa)
of the HMGB1 KO is indicated by white arrows. The area in the white rectangle has been amplified.
The intermediate layer of NPC showed highest apoptotic activity (***). Scale bar indicates 200 µm
in the upper panel and 100 µm in the lower panel. Abbreviations: AOV, ventral anterior olfactory
area; CP, cortical plate; Dpa, dorsal pallium/isocortex; H, hindbrain; HI, hippocampus; IZ, intermediate
zone; M, midbrain; MAR, marginal layer; NPC, neopallial cortex; Spa, subpallium; STR, striatum; SVZ,
subventricular zone; Tel, telencephalic vesicle; VD, ventricles of diencephalon; VZ, ventricular zone.
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The hematoxylin staining of E16 sections confirmed the prominent defects of prenatal forebrain
development in the HMGB1 KO embryos with decreased staining in dorsal telencephalon as compared
to the WT embryos (Figure 2D). The HMGB1 KO mice had much shorter length of the developing cortex
in the direction from rostral to caudal than the WT (Figure 2D). Additionally, HMGB1 KO mice showed
significantly decreased thickness of CP (Figure 2E). Furtermore, we found that the HMGB1 KO mice
had much thinner IZ layer (less than 50%) than the WT at E16 (Figure 2E). In contrast, the thickness
of the layer containing both SVZ and VZ (SVZ/VZ) in the HMGB1 KO mice did not show significant
difference when compared to the WT mice (Figure 2F).
Furthermore, we found that the HMGB1 KO had dramatically upregulated apoptosis in the
dorsal neopallial cortex (NPC) between the ventricular zone (VZ) and the marginal layer (MAR) at E12
(Figure 2G). In contrast, very limited numbers of apoptotic cells were found in the dorsal NPC of the
WT control (Figure 2G). This difference explains the decreased thickness of dorsal telencephalon of
HMGB1 KO embryos.
Taken together, HMGB1 depletion results in the downregulation of neurogenesis and upregulation
of neuronal apoptosis in the developing mouse brain, which causes the severe hypoplasia of the
HMGB1 KO mouse brain.
3.2. Induced Apoptosis and Reduced Neurogenesis in HMGB1 KO Neuronal Cells
We examined apoptosis, proliferation, and differentiation of cultured cells derived from the E16
dorsal telencephalon in order to understand the mechanisms underlying the impaired development of
prenatal cortex found in the HMGB1 KO mice.
After culturing of 2 days, there were more apoptotic cells in the HMGB1 KO cell culture than in
the WT cell culture (Figure 3A). The apoptosis in the HMGB1 KO cells after culturing for four days and
seven days was higher than in WT cells after culturing only for two days (Figure 3B). The apoptotic level
of the cell cultures was analyzed with Tunel fluorescent staining (Figure 3C). In the HMGB1 KO cells
cultured for two days, there were over 10% apoptotic cells. In four days and seven days, the apoptotic
cells in the HMGB1 KO cultures were about 30% of the cell population (Figure 3C). The WT cell culture
showed very low apoptosis at these time points (Figure 3A,B). We found the apoptosis of the HMGB1
KO cells to be dramatically decreased by the addition of exogenous recombinant HMGB1 (10 µg,
but the WT cells were not affected by adding recombinant HMGB1 (Figure 3C).
We also examined the proliferation of cultured cells by immunostaining with anti-PCNA antibody
(Figure 3B). The HMGB1 KO cells showed much less proliferation than the WT cells. About 80% of the
WT cells showed proliferating activity after being cultured for two days and four days, and over 60% of
the WT cells were actively proliferating after seven days (Figure 3D). In the HMGB1 KO cells cultured
for two days and four days, there were only about 40–50% proliferating cells. The proliferation was
more significantly decreased in the KO cells than in the WT control cells after culturing for seven days,
with only about 5% of cells actively proliferating (Figure 3D). The recombinant HMGB1 added into the
culture medium did not rescue the proliferating activity in the HMGB1 KO cells (Figure 3B,D).
Our results show that the HMGB1 KO cells display reduced neurogenesis and increased apoptosis.
After adding recombinant HMGB1 protein, the apoptosis of HMGB1 KO cells was significantly
attenuated, but the proliferation was not restored.
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on the matrix and added into the culture medium at 10 µg/mL. Scale bar indicates 50 µm. (A) and (B)
are the confocal z-stack max projections of 10 µm. (C) The statistics of apoptotic cells in each group
of cultured cells shown in (B). (D) The statistics of proliferating cells in each group of cultured cells
shown in (B). For the statistics in (C) and (D), the cortical neurons from six KO and six WT E16 brains
were collected and cultured for the immunostaining and analysis. For each brain sample, three repeats
were applied. Mean values ± S.D. (error bars) and S.E.M (Boxes) are indicated (n = 6; *** p < 0.001;
** p < 0.01; * p < 0.05; unpaired t-test, two-tailed).
3.3. HMGB1 Depletion Downregulates Neural Differentiation
The HMGB1 KO embryos showed defective brain with grossly decreased hematoxylin staining of
neuronal cells in the prenatal cortex as compared with the WT (Figure 2). This suggested that HMGB1
may have a role in neuronal differentiation.
In cultured primary E16 cortical cells from the HMGB1 KO, both anti-HMGB1 and anti-AMIGO1
immunostaining were negative (Figure 4A, I and II). It confirms that the HMGB1 KO cells did not have
any HMGB1 expression endogenously, or its downstream signal AMIGO1 [40]. As expected from
the morphological analysis of brain development (see above), when compared to the WT cells the
HMGB1 KO cells showed much lower staining by the neuron-specific anti-NeuN and by anti-GFAP
that detects mainly astrocytes (Figure 4A, III). Furthermore, the HMGB1 KO embryos had much less
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differentiating neurons (anti-Tuj1) in the cortical plate (CP) and the intermediate zone (IZ) supporting
the neurogenesis defect in the dorsal telencephalon of the E16 HMGB1 KO (Figure 4A, IV and V &
Figure 4B). Furthermore, the HMGB1 KO embryos had more anti-Tuj1 staining in the ventricular
zone (VZ) than the WT embryos (Figure 4B), which suggested a migration defect of neurons from the
ventricular zone to more superficial parts of the brain. Taken together, the HMGB1 KO mice display
defective neuronal differentiation and migration in the developing cortex.
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Figure 4. Cell differentiation activity in the WT and HMGB1 KO. (A) E16 cortical neuronal cells cultured
for 7 days. (A I) Anti-HMGB1 staining (Green). (A II) Anti-AMIGO1 staining (Red). (A III) Anti-GFAP
(Green) and anti-NeuN (Red) stai ing. DAPI (Blue) was u ed for labeling cell nuclei in (A I–III) Scale bar
indicates 50µm. IV, Anti-β-Tubulin III (Tuj1) staining of E16 sagittal sections. Scale bar indicates 400 µm.
(A V) Anti-β-Tubulin III (Tuj1) staining of E16 sagittal sections. Scale bar indicates 100 µm. (I–V) are the
confocal z-stack max projections of 10µm. (B) Statistics of Tuj1 fluorescent staining intensity in the WT
and HMGB1 E16 dorsal telencephalon. The HMGB1 KO showed significantly decreased Tuj1 staining in
CP and IZ layers compared to the WT. The HMGB1 KO showed higher Tuj1 staining in VZ than the WT.
Statistics has been done by the six brain sections from three embryos for both WT and KO. Mean values ±
S.D. (error bars) and S.E.M (boxes) are indicated (n = 6; *** p < 0.001, unpaired t-test, two-tailed). (C) Flow
cytometry analyses of CD11b+ microglia cells, GLAST-PE+ astrocytes, and O4-APC+ oligodendrocytes in
the E16 WT or HMGB1 KO brains. Each sample was prepared from one single brain. The ratio of each type
of cells among the total cell population was then calculated. (D) Statistics analysis of Flow cytometry results
of the WT and KO mouse brains. The HMGB1 KO mouse brain showed significantly reduced population of
oligodendrocytes and astrocytes compared to the WT controls. Statistics is based on the data from 8 WT and
8 KO brains. Mean values ± S.D. (error bars) and S.E.M (boxes) are indicated (n = 8; ** p < 0.01; * p < 0.05,
unpaired t-test, two-tailed).
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Recent reports have found that the glia precursors in mouse embryos start showing up in
developing forebrain from around E14 [43,44]. We measured the glial cell populations in the E14.5
mouse cortical cells by flow cytometry analysis to investigate the gliogenesis and differentiation
in the HMGB1 KO brains (Figure 4C). In the WT mouse brain, microglia is over 1.1% of the total
cell population, oligodendrocytes about 0.6%, and astrocytes over 6% of the total cell population
(Figure 4D). Microglia was somewhat reduced, and a remarkable reduction was seen in the
numbers of oligodendrocytes and astrocytes (Figure 4D). Taken together, immunostaining and
fluorescence-activated cell sorting (FACS) results have both clearly demonstrated that the HMGB1 KO
mouse has a significant reduction of differentiated neural cell populations.
3.4. HMGB1 Regulates CXCL12/CXCR4 Expression in the Neuronal Progenitors
Similar to HMGB1, CXCL12 and CXCR4 are broadly expressed in the progenitors of developing
brain [29,45,46]. However, the possible role of HMGB1 in regulating CXCL12/CXCR4 signaling in the
nervous system has not been explored.
Firstly, we have evaluated the CXCR4 and CXCL12 expression levels in primary cortical neuronal
cultures derived from the WT and the HMGB1 KO E16 embryos while using immunofluorescence
stainings. The WT cells showed much higher CXCR4 expression than the HMGB1 KO cells, while the
HMGB1 KO cells expressed much higher levels of CXCL12 than the WT cells (Figure 5AI). After adding
the recombinant HMGB1 protein, the HMGB1 KO cells showed increased CXCR4 expression and
decreased CXCL12 expression. In contrast, the WT cells did not show much change of CXCR4 and
CXCL12 expression after adding the recombinant HMGB1 protein (Figure 5AII).
Furthermore, we have quantified the protein expressions in the brain cell cultures by western
blotting (Figure 5B). The plot density analyses clearly showed that the CXCR4 in the HMGB1 KO cells
is only about 40% of that in the WT cells, while CXCL12 in the HMGB1 KO cells is over 30% more than
in the WT cells (Figure 5C). Furthermore, in the HMGB1 KO cells with recombinant HMGB1 protein,
CXCR4 is increased to over 60% of the WT level and CXCL12 has been reduced to almost a normal
level (~ 90% of the level in the WT cells). Different from the KO cells, the WT cells did not show any
significant difference in CXCR4 and CXCL12 expression with or without extra recombinant HMGB1
(Figure 5C).
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Figure 5. Expression of CXCR4 and CXCL12 in cultured HMGB1 KO and WT brain cells. Cells from
cortical cultures of fiv KO and WT E16 brains were collected a d cultu ed fo immunostaining and
Western blotting analysis. (A) Anti-CXCR4 and Anti-CXCL12 staining of E16 cortical neurons cultured
for two days. (I) WT and HMGB1 KO cortical neuronal cells. (II) Cultures ith added recombinant
HMGB1 (recHMGB1;10 µg. Sc le bars i dicate 50 µm. All images are c nfocal z- tack max projections
of 10 µm. (B) Western blotting of E16 neuronal cell samples cultured for two days. The same sample
has been used for all four antibodies in the Western blotting experiment. O lanes with multiple bands
the relevant areas have been encircl d with rectangles. (C) Plot-density analysis of Western blotting
bands of the cultured cell samples. Three repeats were applied with the cell samples collected from five
KO and five WT brains. CXCL12 in the KO is significantly higher than in the other groups. CXCR4
in the KO and in the KO + recHMGB1 is significantly lower than in the WT, but CXCR4 in the KO +
recHMGB1 is significantly higher than in the KO. Mean values ± S.D. (error bars) and SEM (boxes) are
indicated (n = 5; *** p < 0.001; ** p < 0.01; * p < 0.05, unpaired t-test, two-tailed).
We have applied CXCR4 and CXCL12 in situ hybridization on paraffin sections of E16 embryos in
order to study the expressions in the brain tissue (Figure 6A). The HMGB1 KO showed significantly
lower CXCR4 expression than the WT in the forebrain area, especially in the anterior olfactory area,
striatum (STR), and hippocampus (Figure 6A). In contrast, the HMGB1 KO mouse had significantly
higher CXCL12 expression than the WT in the forebrain, which was clearly shown by the more intense
staining at marginal zone (MZ), ganglionic eminence (GE), and nucleus horizontal diagonal band (hdb)
regions (Figure 6A). Furthermore, the western blotting of E16 cortical samples showed that CXCR4 in
the HMGB1 KO was significantly decreased, to lower than 50% of the WT level, and CXCL12 in the
HMGB1 KO was increased to more than two-fold of the WT level (Figure 6B,C).
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Figure 6. Expression of CXCR4 and CXCL12 in developing forebrain. (A) CXCR4 (E16 sagittal 
section), Lhx6 (E14 sagittal section) and CXCL12 (E16 coronal section) in situ hybridization. The 
HMGB1 KO mice showed decreased expression of CXCR4 and Lhx6, but increased CXCL12 in the 
developing cortex compared to the WT mice. Scale bars indicate 1mm. Abbreviations: AOV, ventral 
anterior olfactory area; Di, diencephalon; GE, ganglionic eminence; Hdb, horizontal nucleus of 
diagonal band of Broca; HI, hippocampus; ls, lateral septal nucleus; MF; mesencephalic flexure; MZ, 
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Figure 6. Expression of CXCR4 and CXCL12 in developing forebrain. (A) CXCR4 (E16 sagittal section),
Lhx6 (E14 sagittal section) and CXCL12 (E16 coronal section) in situ hybridization. The HMGB1 KO
mice showed decreased expression of CXCR4 and Lhx6, but increased CXCL12 in the developing
cortex compared to the WT mice. Scale bars indicate 1mm. Abbreviations: AOV, ventral anterior
olfactory area; Di, diencephalon; GE, ganglionic eminence; Hdb, horizontal nucleus of diagonal band
of Broca; HI, hippocampus; ls, lateral septal nucleus; MF; mesencephalic flexure; MZ, Marginal zone;
STR, striatum; Vdb, vertical ucleus of diagonal band of Broca; vpl, ve tral posterior thalamic nucleus
lateral; VZ, Ventricular zone. (B) Western blotting of E16 mouse brain samples. The same pair of
the WT and KO samples has been used for the Western blotting for each antibody in one experiment.
The experiment has been repeated with six pairs of the WT and KO E16 samples. On lanes with
multiple bands the relevant areas have been encircled by rectangles. (C) Plot-density analysis of Western
blotting bands of E16 brain samples. The HMGB1 KO mice showed significantly less expression of
CXCR4, AMIGO1and RAGE than the WT mice. In contrast, the HMGB1 KO mice expressed much
more CXCL12 and β-Catenin than the WT mice. Statistics of plot-density analyses has been obtained
by six repeats. Mean values ± S.D. (error bars) and S.E.M (boxes) are indicated (n = 6; *** p < 0.001;
** p < 0.01; unpaired t-test, two-tailed).
CXCL12/CXCR4 signaling has been reported to be crucial for cortical interneuron migration and
distribution in the developing neocortex [28,47,48]. LIM/homeodomain Lhx6 is the transcription factor
that is preferentially expressed in the cortical interneurons and it is essential for their migration [49].
We therefore applied Lhx6 in situ hybridization on the sections of E14 embryos. The HMGB1 KO
embryos demonstrated significantly lower Lhx6 expression in the MZ and GE than the WT in the
developing forebrain (Figure 6A). Therefore, it appears that Lhx6 is involved in the regulation of
CXCL12/CXCR4 expression in the interneurons of the embryonic brain.
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Western blotting showed that RAGE in the HMGB1 KO brain samples was less than 60% of the WT
control (Figure 6C). Recent studies in immune cells have shown that HMGB1/RAGE signaling increases
the transcription of chemokine receptors to enhance chemotaxis [13,50]. Thus, defective HMGB1/RAGE
signaling elucidates the disrupted CXCL12 and CXCR4 expression in the HMGB1 KO brain.
Taken together, both in vivo and in vitro analyses thus show that HMGB1 depletion in the
embryonic brain upregulates CXCL12, which consequently downregulates CXCR4.
3.5. HMGB1 Depletion Alters Neurodevelopmental Transcription Factors Hierarchy in Developing Forebrain
The vertebrate forebrain development follows a highly ordered stereotypical pattern under the
complex genomic regulatory mechanism [51]. In the early development, the anterior-posterior WNT
gradient is one key factor regulating the anterior forebrain development [52]. We previously reported
that HMGB1 knockdown in zebrafish embryo causes defective forebrain development due to highly
increased Wnt/β-catenin expression [14]. Therefore, we first applied western blotting of E16 cortical
tissues with anti-β-catenin antibody and found that the E16 HMGB1 KO mouse had over two-fold
Wnt/β-catenin expression as compared to the WT (Figure 6B,C). Western blotting results also showed
the down-regulation of AMIGO1 expression in the HMGB1 KO (~20% of the WT level), as in the
neuronal cultures (Figure 4AII).
Foxg1 is a conserved factor regulating Wnt in vertebrate CNS development, and it plays a key
role in neurogenesis and neuronal fate in the forebrain [53,54]. Foxg1 has been found to promote
neurogenesis and inhibit neuronal differentiation in developing forebrain by the transcriptional
repression of Wnt ligands [54]. We carried out Foxg1 in situ hybridization with E16 sections due to the
increased Wnt signaling detected in the HMGB1 KO embryos. The HMGB1 KO mice showed much
lower Foxg1 level along the ventricular layer and the cortical plate than the WT (Figure 7A). Foxg1 has
been proven to be an inhibitor of Wnt signaling in developing forebrain as the downstream signal
of sonic hedgehog (Shh) [55]. Thus, the decreased Foxg1 appears to be the reason for increased Wnt
expression in the HMGB1 KO.
Similar to Foxg1, Tbr2 and Emx2 are two other essential progenitor markers that area expressed
in the dorsal telencephalon [56,57]. Tbr2 in situ hybridization showed that the HMGB1 KO mouse
had significantly reduced Tbr2 expression in the ventricular zone (VZ) of the dorsal telencephalon
(Figure 7B), which likely underscores neurogenesis/proliferation defects shown by BrdU staining
and primary neuronal culture of the E16 prenatal cortex (see above). Furthermore, Emx2 in situ
hybridization confirms the neurogenesis defects in the developing forebrain of the HMGB1 KO. In the
HMGB1 KO E16 dorsal telencephalon, Emx2 expression decreased significantly as compared to the
WT control. The HMGB1 KO clearly showed much less Emx2 expression in the marginal zone (MZ),
ventricular zone (VZ) layer, and striatum (STR) than the WT control (Figure 7C). The decrease of
Foxg1, Tbr2, and Emx2 in the HMGB1 KO forebrain is in agreement with the attenuated neurogenesis
during development.
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Figure 7. Expressions of eurodevelopmental factors in mouse dorsal t le cephalon. (A) In situ
hybridization of Foxg1 with E16 coronal sections. The higher resolution view in the lower panel clearly
showed decreased Foxg1 expression in the CP of HMGB1 KO. The HMGB1 KO mouse also showed
shrunken VZ and LV wh n compared t the T. Scale bars indicat 1 mm in upper panel, and 200 µm,
in the lower panel. (B) In situ hybridization of Tbr2 with E14 coronal sections and E16 saggital section
(lower panel with higher resolution). The HMGB1 KO showed much less Tbr2 positive cells in the
ventricular zone than WT. Scale bars indicate 1 mm in the upper panel and 100 µm in the lower panel.
(C) In situ hybridization of Emx2 in the E16 coronal sections and E16 sagittal sections (lower panel with
higher resolution). The coronal sections show decreased Emx2 expression in the prenatal cortex of the
HMGB1 KO mouse when compared to the WT. Scale bar indicates 1.5 mm. The sagittal sections observed
under higher resolution showed less Emx2 positive cells in the ventricular zone (VZ) and cortical
plate (CP) in the HMGB1 KO as compared to the WT. Scale bar indicates 200 µm, Abbreviations:AH,
Anterior horn; CCi, Cingulate cortex; CPa, Parietal cortex; DT, Dorsal thalamus; GE, Ganglionic
eminence; HI, Hippocampus; IZ, Intermediate zone; LV, Lateral ventricle; MZ, Marginal zone; Vdb,
Vertical nucleus of diagonal band of Broca; STR, Striatum; VZ, Ventricular zone. (D) Expression of brain
developmental factors detected by qRT-PCR. qRT-PCR has been repeated five times with the samples
from five WT and five KO mice. Each sample has been independently tested at least three times.
Mean values ± S.E.M (error bars) are indicated (n = 5). (E) Anti-β-Catenin immunostaining of E16
cortical neurons cultured for two days. Cell nuclei were stained with DAPI (blue). Scale bar indicates
50 µm. (F) Anti-β-Catenin and Anti-RAGE Western blotting of E16 neuronal cell samples cultured for
2 days. On lanes with multiple bands the relevant areas are encircled by rectangles. (G) Plot-density
analysis of Western blotting bands of cultured cell samples. The experiment was repeated with the
cell samples collected from six KO and six WT brains. Mean values ± S.D. (error bars) and S.E.M are
indicated (n = 6; *** p < 0.001; ** p < 0.01; unpaired t-test, two-tailed).
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In addition, we have systematically investigated the expression of developmental transcriptional
factors and other relevant genes that are involved in neurogenesis and differentiation in the developing
brain by qRT-PCR (Figure 7D). When compared with the WT controls, the E16 embryonic brain
of the HMGB1 KO showed decreased expression of several neurogenesis factors, such as Ascl1,
Neurod1, Sox2, Tbr2, and Bcl2. The HMGB1 KO also had significantly decreased expression of the
developmental factors Pax6, Shh, Foxg1, and Emx2. Coincidently, the expression of the differentiation
factors BMP2, BMP4, and Tgfβ1 in the HMGB1 KO embryos were downregulated. Not surprisingly,
the HMGB1 KO displayed approximately 20% lower expression of neuronal growth factors Fgf2,
BDNF, and GDNF. Interestingly, the expression of the synaptogenesis factor Ache was decreased by
about 70% in the HMGB1 KO embryo as compared to the WT control. In contrast, the level of the
apoptotic signals indicator ApoE was 20% higher in the HMGB1 KO than in the WT. The Wnt1 and
Wnt3 levels in the HMGB1 KO were about 80% higher than in the WT controls. This confirmed the
increased Wnt/β-catenin signaling in the HMGB1 KO developing brain. The results of anti-β-Catenin
antibody immunostaining and western blotting with E16 cortical neuronal cultures clearly showed that
Wnt/β-catenin expression was significantly elevated in HMGB1 KO cells (Figure 7E,F). The HMGB1
KO cells that were supplied with recombinant HMGB1 expressed much less Wnt/β -catenin than the
KO, but still around 20% more than the WT (Figure 7G). In addition, we detected strongly decreased
RAGE expression in the HMGB1 KO cells, which was significantly upregulated by supplying with
recombinant HMGB1 (Figure 7F,G). The reversal of the changes in the KO cells by recombinant HMGB1
confirms that HMGB1 can regulate Wnt/β-catenin and RAGE signaling, and the effects in the KO cells
cannot be explained by irreversible nonspecific effects.
Furthermore, the qRT-PCR analysis showed that the HMGB1 KO has decreased CXCL1 expression
(about 70% less) and increased CXCL12 expression (about 100% more) (Figure 7D). The HMGB1 KO
mouse also showed decreased CXCR4 (50% less) and increased CXCR7 (60% more) when compared
with the WT controls. Thus, the qRT-PCR analysis confirmed that HMGB1 depletion significantly
alters chemokine signaling pathways in the embryonic brain shown by immunostaining and Western
blotting experiments (see above, Figure 5).
Taken together, the remarkable changes of gene expressions underscore the observed
morphological defects in the HMGB1 KO embryonic brain. Our results show that HMGB1 is a
conserved factor crucial for neurogenesis and forebrain development.
4. Discussion
4.1. HMGB1 Is Crucial for the Neural Stem Cells/Progenitor Cells in the Developing Brain
Based on in vivo and in vitro results, the HMGB1 KO stem cells/progenitor cells showed
significantly down-regulated proliferation and up-regulated apoptosis as compared to the WT cells
(Figures 1 and 2). Previously, we have found that knocking down HMGB1 increased apoptosis
dramatically in zebrafish developing forebrain [14]. The mechanism by which HMGB1 regulates neural
progenitor proliferation, differentiation and survival is not fully understood. The increased apoptosis
in the HMGB1 KO mouse embryonic brain may be due to the interruption of cytosolic HMGB1/p53
signaling in neuronal progenitors. As a nuclear non-histone protein, HMGB1 is known to facilate p53
binding with DNA in order to promote the autophagy upon inflammatory response [58]. It has been
reported that HMGB1 KO embryonic fibroblasts showed more p53 cytosolic localization, which inhibited
autophagy and induced apoptosis [59]. In addition, the overexpression of Wnt/β-catenin can also
induce the accumulation of p53 protein in the cancer cell cultures [60]. The excessive Wnt/β-catenin
expression in the HMGB1 KO mice may be the key reason of the induced neuronal apoptosis and
reduced proliferation [61].
As a well-known extracellular ligand of RAGE, HMGB1 binding to RAGE is known to enhance
RAGE expression [62]. Therefore, the HMGB1 KO mice had reduced RAGE expression. HMGB1 has
been reported to downregulate apoptosis in tumor cells by binding to RAGE [63]. The HMGB1/RAGE
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signaling may be required for eliminating apoptosis in neuronal progenitors, as in other types of cells.
This inference is supported by our finding that the recombinant HMGB1 can diminish the apoptosis of
neuronal cultures from the HMGB1 KO mice. Other similar works found that extracellular HMGB1
can act extrinsically on its membrane receptor TLR-4 to facilitate the signaling of pro-survival factors
in neuroblastoma [64], and HMGB1/TLR-4 signaling would be activated to inhibit cell apoptosis
in cortex of rats with brain injury [65]. Future work would be required to address the question of
what extracellular receptors are essential in neural progenitors. However, the extracellular HMGB1
receptors, RAGE and/or TLR-4 may not be essential in HMG1-dependent proliferation, since adding
recombinant HMGB1 to the extracellular space did not restore proliferation in the HMGB1 knockout
neuronal cultures. It appears that nuclear interactions of HMGB1 may be required for the proliferation
of neuronal progenitors.
We have also noticed that HMGB1 depletion induced significant downregulation of neuronal
differentiation in developing brain. The FACS results clearly showed that the population of three
types of glia cells, astrocytes, oligodendrocytes, and microglia, were all decreased in the E16 brain
of the HMGB1 KO when compared to the WT. Different types of glia cells showed different changes
in the HMGB1 KO. The population of oligodendrocytes decreased most, and microglia decreased
least. Notably, HMGB1 plays a critical role in promoting RAGE-dependent neuronal differentiation in
cultured neural progenitor cells and neuroblastoma cells [8,66,67]. HMGB1 has also been reported to
be able to promote neuronal differentiation of hippocampal neural progenitor cells via the activation
of the RAGE/NF-κB axis [68]. Our data suggest that HMGB1 is required for maintaining neural
differentiation through RAGE signaling in the developing CNS.
The grossly decreased oligodendrocyte population in the HMGB1 KO mouse embryonic brain
may be caused by the elevated Wnt/β-catenin signaling in vivo. It has been previously shown that
the enhanced Wnt/β-catenin signaling inhibits the generation of oligodendrocyte progenitors before
gliogenesis, and postpones the maturation of oligodendrocyte precursors [69].
In addition to aberrant Wnt/β-catenin signaling, the reduced differentiation and gliogenesis in
the HMGB1 KO may also be due to the significantly decreased AMIGO1. As the member of LRRIG
proteins, AMIGO1 expression has been found to be induced by HMGB1 in neuronal cells, and it can
facilitate neurite outgrowth and neural tract formation in the developing brain [40,41]. In addition to
neurons, AMIGO1 is widely expressed in astrocytes and oligodendrocytes [70]. Studies in vitro have
shown that AMIGO1 depletion downregulates the function of the voltage-gated potassium channel
(Kv2), which can directly inhibit the proliferation of astrocytes [71,72].
We recently reported that HMGB4, a new member in the family of HMGB proteins, regulates the
expression of an oligodendrocyte marker and other neuronal differentiation marker genes [42].
HMGB1 may share a similar mechanism as HMGB4 in regulating neuronal differentiation.
4.2. HMGB1 Regulates Brain Development by Wide Interaction With Essential Developmental
Transcription Factors
Vertebrate brain structures are largely conserved across species. Importantly, the forebrain is
responsible for higher-order functions in mammals. Many neurodevelopmental disorders are due
to genetic defects affecting forebrain development [73]. The HMGB1 KO mouse embryos showed
massive deficiency in brain development. Similar defective CNS development has also been observed
in HMGB1 knockdown in zebrafish embryos [14].
The development of the embryonic forebrain relies on stereotyped expression of a series of
transcription factors that are involved in BMP, TGFβ, and Wnt/β-catenin signaling pathways [51,74].
By both qRT-PCR and Western blotting, we have found elevation of Wnt/β-catenin signaling in the E16
HMGB1 KO embryonic brains. The increase of Wnt/β-catenin signaling is likely of significance, as the
overactivation of Wnt/β-catenin signaling would suppress embryonic forebrain development [75].
Previous reports showed that forebrain defects in the HMGB1 knockdown zebrafish morphants were
also accompanied with the elevation of Wnt signaling [14]. The involvement of HMGB1 in Wnt
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signaling is also found in Caenorhabditis elegans [76]. These findings show that HMGB1 has a
conserved function in regulating Wnt/β-catenin signaling in the developing CNS across species.
HMGB1 is the most abundant nuclear nonhistone protein that was previously considered solely
as an architectural protein supporting the chromatin structure by nonspecific binding to DNA and
facilitating DNA repair [77]. However, HMGB1 has been shown to facilitate transcription activation
by interacting with other nuclear transcription factors [42,78–81]. It is not surprising to find that
HMGB1 depletion induced the aberrant expression of Emx2, Foxg1, and Tbr2, which likely underlies
the significantly reduced neurogenesis and differentiation in the developing forebrain. The qRT-PCR
results confirmed that the important neurogenesis factors Ascl1, Bcl2, Neurod1, Sox2, and Tbr2 were
significantly decreased. The developmental transcription factors that are required for anterior forebrain
development, Emx2, Foxg1, Pax6, and Shh, are significantly downregulated in the HMGB1 KO mouse.
The HMGB1 KO mouse also has a lower expression of BMP and TGFβ cytokines, which suggests that
the development of the HMGB1 KO mouse might be delayed. This might also be one reason of the
smaller size of the HMGB1 KO embryos. Decreases of the growth factors BDNF, Fgf2, and GDNF
should contribute to the defects of brain development in the HMGB1 KO mouse. The decreased
expression of AMIGO1 and ACHE, which are important for the formation of neuronal connections in
differentiated cells, coincide with the defects of differentiation in the HMGB1 KO mouse. It is worth
noting that HMGB1 depletion did not change expression of Notch, the bHLH factors Hes1 and Olig2
(data not shown). This indicates that HMGB1 may not interact with Notch signaling directly in early
developing brain.
4.3. HMGB1 Signaling Through CXCL12/CXCR4 in Developing Brain
Our data clearly showed that the HMGB1 KO embryos had significantly more CXCL12, but much
less CXCR4 than the WT in the developing CNS. HMGB1-CXCL12 heterocomplex and its receptor
CXCR4 have been found to be a key alarmin of inflammation response in the immune system [82].
CXCL12 and CXCR4 have been recently found to be widely involved in brain development by
guiding neuronal precursor migration and maintaining the neuronal progenitor pool in embryonic brain,
in addition to their crucial role in the innate immune system [23,83,84]. Moreover, HMGB1-CXCL12
chemotaxis can act through CXCR4 to activate stem cells to accelerate tissue regeneration [85,86].
By immunostaining of primary cortical neuron cultures, we showed that recombinant HMGB1 added
in the cell cultures significantly alleviated the aberrant CXCL12/CXCR4 expression in the HMGB1 KO
cells when compared to the WT cells. Our results suggest that intrinsic HMGB1 directly regulates
CXCL12/CXCR4 signaling in the neuronal cells, and extrinsic HMGB1 can affect CXCL12/CXCR4
signaling in the cells lacking the intrinsic HMGB1 regulation.
Furthermore, we found that CXCR7, another receptor of CXCL12, was significantly upregulated
in the HMGB1 KO embryos. CXCR7 can regulate CXCL12 availability by acting as a scavenger,
and increased CXCR7 would induce the excessive CXCL12-mediated CXCR4 activation and
degradation [24,87]. The disrupted expression of CXCR4 and CXCR7 in the HMGB1 KO embryonic
brain suggests that HMGB1 is essential for balancing the CXCL12 signal through CXCR4 and CXCR7
in the developing CNS. CXCR4 and CXCR7 have been proven to be crucial for the differentiation and
migration of intermediate progenitor cells [47,88]. The transcription factor Lhx6 is mainly expressed
in interneurons and it controls their migration. The HMGB1 KO embryos showed decreased Lhx6
expressing interneurons in the developing cortex suggesting a migration defect.
The dramatically increased Wnt/β-catenin signaling in the HMGB1 KO may also rely on the
elevated CXCL12, since CXCL12 can induce the accumulation of β-catenin in neuronal progenitors [89].
We suggest that the disrupted CXCL12 signaling through the CXCR4/CXCR7 receptors contributes to
the defects seen in the developing CNS of the HMGB1 KO embryos.
As a difference from the CXCL12 expression, we found that CXCL1 expression is significantly
decreased in the HMGB1 KO embryos, as shown by qRT-PCR. This suggests that HMGB1 ablation
results in specific CXCL12 elevation instead of a general activation of chemokine expression. CXCL1 is
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known to be one of the key regulators of neuronal progenitor proliferation and differentiation [90].
The downregulation of CXCL1 is also likely to contribute to the decreased neurogenesis and
differentiation in the HMGB1 KO embryos.
4.4. Is the HMGB1-Dependent Neurogenesis Required for Adult Plasticity Underlying Memory and Learning?
Plasticity and regeneration in the adult brain frequently recapitulate developmental mechanisms.
For example, the functional brain plasticity that is required for memory and learning depends on
adult neurogenesis from stem cells in the hippocampus [91,92]. It is clear that HMGB1 displays a
massive expression in embryonic brain as compared to the adult brain [3], but a high local HMGB1
expression remains in hippocampus, olfactory bulb, and ventricular cell layers in the adult brain [18,93].
Most intriguingly, the expression pattern in the adult corresponds to the brain areas that are still
capable of neurogenesis, suggesting a role for HMGB1 in neural stem cells/progenitor cells as in the
developing brain.
Combining the current data that HMGB1 regulate neurogenesis in the embryonic brain, localizes
to neurogenic areas in the adult and that neurogenesis in the adult hippocampus is required for
memory and learning, raises the question whether HMGB1 is involved in the regulation of cognitive
functions. The knockout mice used in the current study survive only shortly after birth, and do
not therefore allow for studies on memory and learning or other cognitive functions. Interestingly,
studies on HMGB1 in traumatic brain injury using regulated global knockout in adult mice have very
recently shown that the HMGB1 deficient mice display blunted memory and learning, even without
any trauma [94]. No explanation has been available for this intriguing finding. Taken together,
we suggest that HMGB1-dependent neurogenesis from stem cells/progenitor cells in the hippocampal
regions of the adult, such as the dentate gyrus, is required for functional plasticity underlying memory
and learning.
Furthermore, a recent report has identified HMGB1 depletion as a candidate causing intellectual
disability and microcephaly in human [95]. Gene defects causing an intellectual disability are often
localized to genes that regulate brain plasticity [95,96], which would be compatible with the role
of HMGB1 in brain plasticity and as a candidate gene linked to intellectual disability. The current
findings that HMGB1 depletion causes a disrupted expression of several genes that are required for
neurogenesis and neuronal migration support the finding that HMGB1 depletion during embryonic
development causes microcephaly and intellectual disability.
5. Concluding Remarks
Our study uncovers the critical role of HMGB1 in mouse forebrain development. The HMGB1 KO
mouse showed disrupted expression of several neurodevelopmental factors regulating neurogenesis.
Together with previous reports, we confirmed that HMGB1 is crucial in the CNS development across
species and may, in addition, regulate plasticity-related functions of the adult brain, which deserves
further studies. Furthermore, our data have evidenced that the HMGB1-CXCL12/CXCR4 signaling
found in the innate immune system also exists in the mouse developing nervous system. The universal
HMGB1 regulation of CXCL12/CXCR4 signaling in both the immune system and the central nervous
system suggests that HMGB1 is a crucial messenger of neuro-immune crosstalk. Future studies with
conditional HMGB1 KO mouse model would help us to shed light on the interactions and signal
transduction between the immune system and the nervous system.
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